-
Something wrong with this record ?
PETC/CT with 18F-Choline localizes hyperfunctioning parathyroid adenomas equally well in normocalcemic hyperparathyroidism as in overt hyperparathyroidism
I. Bossert, S. Chytiris, M. Hodolic, L. Croce, L. Mansi, L. Chiovato, G. Mariani, G. Trifirò,
Language English Country Italy
Document type Journal Article
- MeSH
- Choline analogs & derivatives MeSH
- Adult MeSH
- Hypercalcemia diagnostic imaging pathology surgery MeSH
- Hyperparathyroidism diagnostic imaging pathology surgery MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Parathyroid Neoplasms diagnostic imaging pathology surgery MeSH
- Follow-Up Studies MeSH
- Positron Emission Tomography Computed Tomography methods MeSH
- Prognosis MeSH
- Radiopharmaceuticals MeSH
- Radionuclide Imaging methods MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Ultrasonography methods MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
PURPOSE: Identification of pathologic parathyroid glands in primary hyperparathyroidism, traditionally based on neck ultrasound (US) and/or 99mTc-Sestamibi scintigraphy, can be challenging. PET/CT with 18F-Fluorocholine (18F-FCH) might improve the detection of pathologic parathyroid glands. We aimed at comparing the diagnostic performance of 18F-FCH-PET/CT with that of dual-phase dual-isotope parathyroid scintigraphy and neck US. METHODS: Thirty-four consecutive patients with primary hyperparathyroidism were prospectively enrolled, 7 had normocalcemic hyperparathyroidism, and 27 had classic hypercalcemic hyperparathyroidism. All patients underwent high-resolution neck US, dual-phase dual-isotope 99mTc-Pertechnetate/99mTc-Sestamibi scintigraphy, and 18F-FCH-PET/CT. RESULTS: In the whole patients' group, the detection rates of the abnormal parathyroid gland were 68% for neck US, 71% for 18F-FCH-PET/CT, and only 15% for 99mTc-Sestamibi scintigraphy. The corresponding figures in normocalcemic and hypercalcemic hyperparathyroidism were 57 and 70% for neck US, 70 and 71% for 18F-FCH-PET/CT, and 0 and 18% for 99mTc-Sestamibi scintigraphy, respectively. In the 17 patients in whom the abnormal parathyroid gland was identified, either at surgery or at fine needle aspiration cytology/biochemistry, the correct detection rate was 82% for neck US, 89% for 18F-FCH-PET/CT, and only 17% for 99mTc-Sestamibi scintigraphy. CONCLUSIONS: 18F-FCH-PET/CT can be considered a first-line imaging technique for the identification of pathologic parathyroid glands in patients with normocalcemic and hypercalcemic hyperparathyroidism, even when the parathyroid volume is small.
Inter Universitary Research Center for Sustainable Development Naples Italy
Regional Center of Nuclear Medicine University of Pisa Pisa Italy
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035083
- 003
- CZ-PrNML
- 005
- 20191015092326.0
- 007
- ta
- 008
- 191007s2019 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s40618-018-0931-z $2 doi
- 035 __
- $a (PubMed)30094743
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Bossert, I $u Unit of Nuclear Medicine, ICS Maugeri, 27100, Pavia, Italy.
- 245 10
- $a PETC/CT with 18F-Choline localizes hyperfunctioning parathyroid adenomas equally well in normocalcemic hyperparathyroidism as in overt hyperparathyroidism / $c I. Bossert, S. Chytiris, M. Hodolic, L. Croce, L. Mansi, L. Chiovato, G. Mariani, G. Trifirò,
- 520 9_
- $a PURPOSE: Identification of pathologic parathyroid glands in primary hyperparathyroidism, traditionally based on neck ultrasound (US) and/or 99mTc-Sestamibi scintigraphy, can be challenging. PET/CT with 18F-Fluorocholine (18F-FCH) might improve the detection of pathologic parathyroid glands. We aimed at comparing the diagnostic performance of 18F-FCH-PET/CT with that of dual-phase dual-isotope parathyroid scintigraphy and neck US. METHODS: Thirty-four consecutive patients with primary hyperparathyroidism were prospectively enrolled, 7 had normocalcemic hyperparathyroidism, and 27 had classic hypercalcemic hyperparathyroidism. All patients underwent high-resolution neck US, dual-phase dual-isotope 99mTc-Pertechnetate/99mTc-Sestamibi scintigraphy, and 18F-FCH-PET/CT. RESULTS: In the whole patients' group, the detection rates of the abnormal parathyroid gland were 68% for neck US, 71% for 18F-FCH-PET/CT, and only 15% for 99mTc-Sestamibi scintigraphy. The corresponding figures in normocalcemic and hypercalcemic hyperparathyroidism were 57 and 70% for neck US, 70 and 71% for 18F-FCH-PET/CT, and 0 and 18% for 99mTc-Sestamibi scintigraphy, respectively. In the 17 patients in whom the abnormal parathyroid gland was identified, either at surgery or at fine needle aspiration cytology/biochemistry, the correct detection rate was 82% for neck US, 89% for 18F-FCH-PET/CT, and only 17% for 99mTc-Sestamibi scintigraphy. CONCLUSIONS: 18F-FCH-PET/CT can be considered a first-line imaging technique for the identification of pathologic parathyroid glands in patients with normocalcemic and hypercalcemic hyperparathyroidism, even when the parathyroid volume is small.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a cholin $x analogy a deriváty $7 D002794
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperkalcemie $x diagnostické zobrazování $x patologie $x chirurgie $7 D006934
- 650 _2
- $a hyperparatyreóza $x diagnostické zobrazování $x patologie $x chirurgie $7 D006961
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nádory příštítného tělíska $x diagnostické zobrazování $x patologie $x chirurgie $7 D010282
- 650 _2
- $a PET/CT $x metody $7 D000072078
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a radioisotopová scintigrafie $x metody $7 D011877
- 650 _2
- $a radiofarmaka $7 D019275
- 650 _2
- $a ultrasonografie $x metody $7 D014463
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chytiris, S $u Unit of Internal Medicine and Endocrinology, ICS Maugeri I.R.C.C.S, University of Pavia, Via S. Maugeri 10, 27100, Pavia, Italy.
- 700 1_
- $a Hodolic, M $u Nuclear Medicine Research Department, Iason, Graz, Austria. Nuclear Medicine Department, Iason, Graz, Austria. Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic. Nuclear Medicine Department, Policlinico S. Orsola Malpighi, University of Bologna, Bologna, Italy.
- 700 1_
- $a Croce, L $u Unit of Internal Medicine and Endocrinology, ICS Maugeri I.R.C.C.S, University of Pavia, Via S. Maugeri 10, 27100, Pavia, Italy.
- 700 1_
- $a Mansi, L $u Inter-Universitary Research Center for Sustainable Development (CIRPS), Naples, Italy.
- 700 1_
- $a Chiovato, L $u Unit of Internal Medicine and Endocrinology, ICS Maugeri I.R.C.C.S, University of Pavia, Via S. Maugeri 10, 27100, Pavia, Italy. luca.chiovato@icsmaugeri.it.
- 700 1_
- $a Mariani, G $u Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy.
- 700 1_
- $a Trifirò, G $u Unit of Nuclear Medicine, ICS Maugeri, 27100, Pavia, Italy.
- 773 0_
- $w MED00002652 $t Journal of endocrinological investigation $x 1720-8386 $g Roč. 42, č. 4 (2019), s. 419-426
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30094743 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191015092752 $b ABA008
- 999 __
- $a ok $b bmc $g 1451743 $s 1073633
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 42 $c 4 $d 419-426 $e 20180809 $i 1720-8386 $m Journal of endocrinological investigation $n J Endocrinol Invest $x MED00002652
- LZP __
- $a Pubmed-20191007
